Verdicts & Settlements
On behalf of our clients and the United States government, Young Law Group’s attorneys have taken on some of world’s largest corporations, including drug manufacturers, defense contractors, financial institutions, and insurance companies. We have recovered more than $3 billion for the federal government in whistleblower lawsuits.
Our whistleblower attorneys have represented clients in numerous actions involving the False Claims Act as well as the whistleblower programs of the IRS, SEC, CFTC and NHTSA. Some of our noteworthy recoveries include:
- United States ex rel. Bilotta v. Novartis Pharmaceuticals Corp., No. 11-cv-0071 (S.D.N.Y.). $678 million settlement of allegations that the company paid kickbacks to physicians to induce them to prescribe certain of the company’s drugs.
- United States ex rel. Arnstein and Senousy v. Teva Pharmaceuticals USA, Inc., No. 1:13-cv-03702 (S.D.N.Y.). $54 million settlement involving allegations that the company paid doctors to speak at sham speaker programs to increase prescriptions for two of the company’s drugs.
- United States ex. rel. Kruszewski v. Pfizer, Inc., No. 07-cv-4106 (E.D. Pa.). Pfizer pled guilty to criminal conduct and paid $2.3 billion in criminal and civil fines, penalties, and damages. The company agreed to a global settlement which included allegations in nine separate whistleblower lawsuits that Pfizer illegally promoted four of its drugs and caused false claims to be submitted to government health care programs.
- United States ex. rel. Peiken v. Salix Pharmaceuticals, Inc., No. 1:12-cv-03870 (S.D.N.Y.). $54 million settlement of False Claims Act allegations involving the company’s payment of kickbacks to physicians who spoke at sham speaker programs.
- U.S. ex. rel. Paccione v. Cephalon, No. 03-cv-6268 (E.D. Pa.). $425 Million settlement of allegations that the company engaged in unlawful off-label marketing of four of its drugs.
- U.S. ex. rel. Curren v. Denver Health Hospital, No. 09-cv-01752 (D. Colo.) – $6.3 million settlement of allegations that the hospital submitted false claims to Medicare and Medicaid for reimbursement of inpatient level services when only outpatient or observation services were provided.
- U.S. ex. rel. Mihalovic v. ECL Solutions, Ltd., No. 12-cv-758 (D. Del.) – a qui tam False Claims Act complaint filed by Young Law Group’s predecessor firm alleged that the defendant falsely represented that the products sold to the United States government complied with the Buy American Act and the Trade Agreements Act. A criminal action brought by the Department of Justice resulted in a guilty plea and a forfeiture judgment of nearly $1.1 million.
- First-ever mandatory IRS Whistleblower Reward under § 7623(b) – the IRS awarded $4.5 million to an anonymous client who reported information involving tax evasion by a Fortune 500 company.